Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas

8Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background: This is a literature review aiming to provide an update about the recent findings related to the efficacy of middle meningeal artery embolization (MMAE) in the treatment of chronic subdural hematomas (cSDHs), comparison with conventional therapy and deduction of the current recommendations and indications. Methods: The literature is reviewed using a search through the PubMed index using keywords. Studies are then screened, skimmed, and thoroughly read. 32 studies fulfilled the inclusion criteria and are included in the study. Results: Five indications for the application of MMA embolization (MMAE) are deducted from the literature. The usage as a preventive measure after surgical treatment of symptomatic cSDHs in patients with a high risk of recurrence and the usage as a standalone procedure has been the most common reasons for indication of this procedure. Rates of failures for the aforementioned indications have been 6.8% and 3.8%, respectively. Conclusion: The safety of MMAE as a procedure is regarded as a general theme in the literature and can be considered for future applications. Usage of this procedure in clinical trials with more patient segregation and timeframe assessment relative to surgical intervention are recommendations of this literature review.

Cite

CITATION STYLE

APA

Msheik, A., Fares, Y., Mohanna, M., Aoude, A., Shkeir, M., Chehade, F., … Mohanna, A. (2023). Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas. Surgical Neurology International. Scientific Scholar. https://doi.org/10.25259/SNI_1096_2022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free